Memora Health

News

Investor sentiment for companies operating in the digital health category is likely to be somewhat shaken by the bankruptcy of pioneer

News

Patients in the EU with the ultra-rare disease WHIM syndrome now have their first approved treatment, Norgine's Xolremdi.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.